EUVIMEDEUVIMED entdecken
Open Access

Characterization of spike S1/S2 processing and entry pathways of lentiviral pseudoviruses bearing seasonal human coronaviruses NL63, 229E, and HKU1 spikes

Sabari Nath Neerukonda, Russell Vassell, Sabrina Lusvarghi, Shufeng Liu iD, Adovi Akue, Mark Kukuruga, Tony T Wang iD, Carol D Weiss iD, Wei Wang iD

Microbiology Spectrum · 2025

DOI: 10.1128/spectrum.02808-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2025. Verfasst von Sabari Nath Neerukonda und 8 weiteren Autor:innen. Beteiligte Einrichtung: Office of Vaccine Research and Review, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA. Hauptthemen laut MEDLINE: Spike Glycoprotein, Coronavirus, Virus Internalization, Coronavirus NL63, Human, Coronavirus 229E, Human. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although much has been learned about the entry mechanism of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), many details of the entry mechanisms of seasonal human coronaviruses (HCoVs) remain less well understood. In the present study, we used 293T cell lines stably expressing angiotensin converting enzyme (ACE2), aminopeptidase N (APN), or transmembrane serine protease 2 (TMPRSS2), which support high-level transduction of lentiviral pseudoviruses bearing spike proteins of seasonal HCoVs, HCoV-NL63, -229E, or -HKU1, respectively, to compare spike processing and virus entry pathways among these viruses. Our results showed that the entry of HCoV-NL63, -229E, and -HKU1 pseudoviruses into cells is sensitive to endosomal acidification inhibitors (chloroquine and NH 4 Cl), indicating entry via the endocytosis route. Although TMPRSS2 expression on target cell surface was required for HCoV-HKU1 spike-mediated entry and cell–cell fusion, we found that only the serine protease domain of TMPRSS2 and not the serine protease activity of TMPRSS2 was required for viral entry via endocytic route. However, the serine protease activity of TMPRSS2 and a furin processing site (RKRR) at the S1/S2 junction were essential for efficient HCoV-HKU1 spike-mediated cell–cell fusion. Additionally, we show that dibasic and monobasic arginine residues at the S1/S2 junctions of spike proteins of HCoV-NL63 and -229E are essential for virus entry, but multi-basic furin processing site at the S1/S2 junction was dispensable for HCoV-HKU1 viral entry. Our findings highlight features of the entry mechanisms of seasonal HCoVs that may support the development of novel treatment strategies. IMPORTANCE Details of the entry mechanisms of seasonal human coronaviruses (HCoVs) remain to be fully explored. To investigate spike-mediated virus entry of HCoV-NL63, -229E, and -HKU1 CoVs, we employed 293T cells that stably express angiotensin converting enzyme (ACE2), aminopeptidase N (APN), or transmembrane serine protease 2 (TMPRSS2) to study entry mechanisms of pseudoviruses bearing spike proteins of HCoV-NL63, -229E, and -HKU1, respectively. We found that HCoV-NL63, -229E, and -HKU1 pseudoviruses entered cells via the endocytic route independently of cellular serine protease activity and therefore likely depended on endosomal cathepsin activity. Furthermore, we showed that arginine amino acids in S1/S2 junctions of HCoV-NL63 and -229E spikes were essential for entry but not essential for HCoV-HKU1 entry. Our results provide new insights into the S1/S2 junctional residues, cellular receptors, and protease requirements for seasonal HCoV pseudovirus entry into cells that may support the development of novel inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spike Glycoprotein, CoronavirusVirus InternalizationCoronavirus NL63, HumanCoronavirus 229E, HumanLentivirusHumansSerine EndopeptidasesHEK293 CellsSARS-CoV-2Angiotensin-Converting Enzyme 2CD13 AntigensEndocytosis

Stichwörter der Autor:innen

cell–cell fusionneutralizationpseudovirusseasonal coronavirustransmembrane serine protease 2virus entry

Substanzen

Spike Glycoprotein, CoronavirusSerine EndopeptidasesTMPRSS2 protein, humanAngiotensin-Converting Enzyme 2spike protein, SARS-CoV-2ACE2 protein, humanCD13 Antigens

Autor:innen und Institutionen

  • Office of Vaccine Research and Review, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.

ORCID-Profile: Shufeng Liu, Tony T Wang, Carol D Weiss, Wei Wang

Zitieren

APA

Neerukonda, S. N., Vassell, R., Lusvarghi, S., Liu, S., Akue, A., Kukuruga, M., Wang, T. T., Weiss, C. D., & Wang, W. (2025). Characterization of spike S1/S2 processing and entry pathways of lentiviral pseudoviruses bearing seasonal human coronaviruses NL63, 229E, and HKU1 spikes. Microbiology Spectrum. https://doi.org/10.1128/spectrum.02808-24

Vancouver

Neerukonda SN, Vassell R, Lusvarghi S, Liu S, Akue A, Kukuruga M, et al. Characterization of spike S1/S2 processing and entry pathways of lentiviral pseudoviruses bearing seasonal human coronaviruses NL63, 229E, and HKU1 spikes. Microbiology Spectrum. 2025. doi:10.1128/spectrum.02808-24

BibTeX
@article{Neerukonda2025,
  author = {Neerukonda, Sabari Nath and Vassell, Russell and Lusvarghi, Sabrina and Liu, Shufeng and Akue, Adovi and Kukuruga, Mark and Wang, Tony T and Weiss, Carol D and Wang, Wei},
  title = {Characterization of spike S1/S2 processing and entry pathways of lentiviral pseudoviruses bearing seasonal human coronaviruses NL63, 229E, and HKU1 spikes},
  journal = {Microbiology Spectrum},
  year = {2025},
  doi = {10.1128/spectrum.02808-24}
}
Kostenlos starten →